Development Core

$303,355P30FY2009AINIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

Paper 39406776 Paper 38975346 Paper 38947062 Paper 38518375 Paper 37880260 Paper 37516317 Paper 37036417 Paper 36844399 Paper 36711878 Paper 36538527 Paper 36399528 Paper 36231015 Paper 36062329 Paper 35794145 Paper 35679138 Paper 35414140 Paper 35143611 Paper 34989321 Paper 34889103 Paper 34799643 Paper 34718349 Paper 34634187 Paper 34373735 Paper 34335611 Paper 34290089 Paper 34242617 Paper 34161280 Paper 34107377 Paper 34092059 Paper 33743191 Paper 33556369 Paper 33547365 Paper 33485667 Paper 33159886 Paper 32792548 Paper 32695845 Paper 32592180 Paper 32541040 Paper 32500803 Paper 32345916 Paper 32320644 Paper 32298026 Paper 32142667 Paper 31964753 Paper 31838858 Paper 31836691 Paper 31765380 Paper 31759187 Paper 31697807 Paper 31696517 Paper 31618426 Paper 31515251 Paper 31451770 Paper 31396406 Paper 31257132 Paper 31198906 Paper 31112138 Paper 31076527 Paper 31068405 Paper 31067451 Paper 30982770 Paper 30948267 Paper 30941128 Paper 30921351 Paper 30878879 Paper 30786885 Paper 30777858 Paper 30761142 Paper 30696983 Paper 30696942 Paper 30646957 Paper 30633903 Paper 30610193 Paper 30501557 Paper 30415998 Paper 30401712 Paper 30388424 Paper 30358421 Paper 30305617 Paper 30267595 Paper 30223431 Paper 30204240 Paper 30165653 Paper 30135482 Paper 30075114 Paper 30070147 Paper 30016639 Paper 30016541 Paper 30013058 Paper 30010888 Paper 29980437 Paper 29939180 Paper 29934134 Paper 29895199 Paper 29848758 Paper 29751067 Paper 29721072 Paper 29679656 Paper 29653981 Paper 29642890

Abstract

The purpose of the CFAR Developmental Core is to foster the development of HIV/AIDS-related research at Baylor and UTHouston, This is accomplished in several ways, two of which are new to this resubmission. First, investigator-initiated scientific studies are supported to develop preliminary data for research applications. Types of eligible projects include pilot and feasibility studies and collaborative translational research projects. Second, a new effort, designated "Collaborative Core Initiatives", targets specific research gaps and opportunities at our CFAR. Third, also new, some funds are dedicated to support the development of Scientific Programs that draw on strengths, opportunities, and expertise at our CFAR. We have chosen to emphasize first "HIV and Coinfections", focusing on Mycobacterium tuberculosis. Awards are made following a rigorous peer review system. Funds also may be used to assist in recruitment of new faculty engaged in HIV/AIDS research. Finally, new to this application, we will provide a comprehensive mentoring program to help the career development of junior investigators involved in HIV/AIDS research. This core has an impressive record of accomplishments from the former Baylor CFAR. From 1995 to 2001, Developmental awards ($646,005) supported 33 projects on both basic and clinical research topics. Twenty-one of the 33 awardees obtained external funding totaling over $12.4 million within 3 years following their award, representing a success rate of 63% and a 19-fold leveraging of CFAR funds invested. Grantees published over 190 articles during the 3-year follow-up period. Developmental funds have also been used to assist in the recruitment of two junior faculty members. We are requesting $220,000/year in Years 11-15 to continue these developmental efforts. Allocations of Developmental funds among the various developmental programs each year will be determined by the CFAR Internal Advisory Committee. The Core is led by Dr. Janet Butel, Director, and two Associate Directors, Drs. Mary Estes (Baylor) and Mary Velasquez (UTHouston). Dr. Velasquez is a new appointment with this resubmission.

View original record on NIH RePORTER →